Helixa has been acquired by Telmar
Helixa has been acquired by Telmar, a portfolio company of Boathouse Capital.
Helixa is a forward-thinking audience insights platform that uses ethical AI and machine learning technology to connect data sources in one easy to use tool. Helixa helps brands and marketers connect in a more deep and meaningful way with audiences that matter most to them, and ensures that detailed research and a respect for privacy are not in conflict.
Telmar provides strategic targeting and media planning solutions to advertisers, agencies, media companies, and data suppliers. Over 25,000 users across 100 countries use Telmar systems to analyze thousands of consumer and media data sets to assess target markets, audience reach and frequency, and media performance. Data sets can be either syndicated data to which rightful access has been granted by the data supplier, or customers’ own proprietary data. Telmar provides data integration services which support fix fusion, ascription, and Telmar’s leading data integration technique: MultiBasing™. Telmar’s platform of systems is cloud based with applications available via desktop browsers and iOS mobile.
One of Oaklins’ TMT teams in New York acted as the exclusive financial advisor to the seller, Helixa, in this transaction.
Contáctese con el equipo de la transacción
Ken Sonenclar
Oaklins DeSilva+Phillips
John Matthews
Oaklins DeSilva+Phillips
Elaine Riddell
Oaklins DeSilva+Phillips
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más